DOI: 10.1055/s-00000054

Pharmacopsychiatry

Ausgabe 06 · Volume 40 · November 2007 DOI: 10.1055/s-002-7528

Additional Abstracts (to Pharmacopsychiatry 2007; 40: 205–255)
25th Symposium of the AGNP
Munich, 3rd–6th October 2007

Chairs: Prof. Dr. W. Wolfgang Fleischhacker, Innsbruck, Dr. Werner Kadus, Karlsruhe
Abstracts (HTML) Autorenliste

Original Paper

257
Marinis, T. De; Saleem, P. T.; Glue, P.; Arnoldussen, W. J.; Teijeiro, R.; Lex, A.; Latif, M. A.; Medori, R.: Switching to Long-Acting Injectable Risperidone is Beneficial with Regard to Clinical Outcomes, Regardless of Previous Conventional Medication in Patients with Schizophrenia
264
de Haan, L.; van Amelsvoort, T.; Dingemans, P.; Linszen, D.: Risk Factors for Medication Non-Adherence in Patients with First Episode Schizophrenia and Related Disorders; A Prospective Five Year Follow-Up
269
Xiang, Y.-T.; Weng, Y.-Z.; Leung, C.-M.; Tang, W.-K.; Ungvari, G. S.: Clinical and Social Determinants of Long-Term Use of Benzodiazepines and its Impact on Quality of Life of Chinese Schizophrenia Patients
275
Gallhofer, B.; Jaanson, P.; Mittoux, A.; Tanghøj, P.; Lis, S.; Krieger, S.: Course of Recovery of Cognitive Impairment in Patients with Schizophrenia: A Randomised Double-blind Study Comparing Sertindole and Haloperidol

Letter

287
Greiner, C.; Wittmann, M.; Haen, E.: Lamotrigine Serum Concentrations under Valproate Comedication: “Contraindication” or “Safe Combination”?
289
Ghanizadeh, A.: Sertraline and Tic: Case Report
291
Soyka, M.; Täschner, B.; Clausius, N.: Neuroleptic Treatment of Alcohol Hallucinosis: Case Series
292
Biermann, T.; Bleich, S.; Kornhuber, J.; Hillemacher, T.: Pregabalin in Benzodiazepine Withdrawal
294
Blaschke, D.; Parwani, A. S.; Huemer, M.; Rolf, S.; Boldt, L.-H.; Dietz, R.; Haverkamp, W.: Torsade de Pointes during Combined Treatment with Risperidone and Citalopram
295
Oulis, P.; Koulouris, G. C.; Konstantakopoulos, G.; Masdrakis, V. G.: Marked Elevation of Creatine Kinase with Sertindole: A Case Report